in

Sequoia Capital, Vertex Ventures join Chinese biotech startup’s $226m series B round




Part of the funds will be used to conduct clinic tests of HPV 9-valent vaccine and recombinant Covid vaccine.



Source link

What do you think?

Written by wEcZAfTxH1

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

Loading…

0

Comments

0 comments

Israel R&D team said likely behind Apple’s ‘revolutionary’ chip for laptops

Israeli Study: It’s OK To Laugh About COVID-19